Edition:
United Kingdom

Akcea Therapeutics Inc (AKCA.OQ)

AKCA.OQ on NASDAQ Stock Exchange Global Select Market

21.20USD
24 May 2019
Change (% chg)

$-0.17 (-0.80%)
Prev Close
$21.37
Open
$21.48
Day's High
$22.34
Day's Low
$21.12
Volume
41,407
Avg. Vol
81,939
52-wk High
$40.60
52-wk Low
$19.70

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.47 December 25 May 2019

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 2 2 2 2
(3) HOLD 2 2 2 2
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.20 2.20 2.20 2.20

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-19 4 21.38 31.10 9.20 259.40
Quarter Ending Sep-19 4 26.80 44.40 11.60 319.70
Year Ending Dec-19 5 255.21 299.90 199.80 443.76
Year Ending Dec-20 5 380.22 742.00 66.90 405.51
Earnings (per share)
Quarter Ending Jun-19 5 -0.47 -0.08 -0.66 2.02
Quarter Ending Sep-19 5 -0.45 0.02 -0.66 2.58
Year Ending Dec-19 5 -0.49 1.71 -1.60 0.30
Year Ending Dec-20 5 -0.35 5.31 -2.36 -0.82

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-19 168.60 163.82 4.78 2.84
Quarter Ending Dec-18 17.76 10.20 7.56 42.57
Quarter Ending Sep-18 16.82 19.24 2.42 14.41
Quarter Ending Jun-18 12.56 18.32 5.77 45.93
Quarter Ending Mar-18 12.12 17.11 4.98 41.11

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-19 21.38 21.38 21.83 21.83 259.40
Quarter Ending Sep-19 26.80 26.80 29.90 29.90 319.70
Year Ending Dec-19 255.21 255.21 276.93 276.93 443.76
Year Ending Dec-20 380.22 380.22 454.74 454.74 405.51

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-19 0 0 1 1
Quarter Ending Sep-19 0 0 1 1
Year Ending Dec-19 0 0 1 3
Year Ending Dec-20 0 0 2 2
Earnings